CSL Behring at SCOPE 2027
Mar 1–4, 2027 Orlando, FL ~5k attendees Website
CSL Behring brings 2 presentations to SCOPE 2027 in Orlando. Its sessions cover the gap between clinical care and research in enrollment, and building risk-based quality management from scratch. A concrete topic is setting critical-to-quality factors and overseeing CROs effectively in a growing oncology biotech.
| Organization | SCOPE 2027 Attendance |
|---|---|
CSL Behring King of Prussia, PA | |
Business of CSL that makes plasma-derived and recombinant therapies for immune deficiencies, bleeding disorders and other rare diseases. | Panel Mon Mar 1 5:04pm–5:40pm KEYNOTE INTERACTIVE PANEL: Solving the Enrollment Crisis: Bridging Clinical Care and Clinical Research Patient recruitment and engagement Talk Wed Mar 3 9:00am–9:20am Building RBQM from the Ground up: Establishing Critical-to-Quality Factors and Effective CRO Oversight in a Growing Oncology Biotech Quality, monitoring and safetyOutsourcing and budgeting |
Instantly find 20 buyers from CSL Behring
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction